Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- MEK-1 2 ERK-1 2 MAPK-1 3 p38 p40 p41 p42 PRKM2 PRKM-2 ERT2 ERT1 ERT-1 2
- Product Overview:
Extracellular-signal-regulated kinase/mitogen-activated protein kinases (ERK/MAPKs) are a widely conserved family of serine/threonine protein kinases and essential components of the MAP kinase signaling cascade.{53684,53685} Upon extracellular stimulation with mitogens, growth factors, or cytokines, a sequential three-part signaling cascade is initiated that terminates with phosphorylation of ERK/MAPK by MEK1 or MEK2. Activated ERK/MAPK is translocated to the nucleus where it regulates transcription factor activity and gene transcription for a variety of cellular processes including cell proliferation, differentiation, and stress response. Misregulation of the MAP kinase cascade drives development of various cancers. ERK1/MAPK3 and ERK2/MAPK1 are two key members of the ERK/MAPK family encoded by MAPK3 and MAPK1, respectively, in humans and are expressed in all tissues. Cayman’s ERK/MAPK Polyclonal Antibody can be used for immunocytochemistry (ICC) and Western blot (WB) applications. The antibody recognizes ERK1/MAPK3 and ERK2/MAPK1 at approximately 44 and 42 kDa, respectively from human, mouse, and rat samples.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.